GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gossamer Bio Inc (STU:4GB) » Definitions » Change In Prepaid Assets

Gossamer Bio (STU:4GB) Change In Prepaid Assets : €-0.1 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Gossamer Bio Change In Prepaid Assets?

Gossamer Bio's Change In Prepaid Assets for the quarter that ended in Mar. 2025 was €-0.9 Mil. It means Gossamer Bio's Prepaid Assets declined by €0.9 Mil from Dec. 2024 to Mar. 2025 .

Gossamer Bio's Change In Prepaid Assets for the fiscal year that ended in Dec. 2024 was €0.1 Mil. It means Gossamer Bio's Prepaid Assets increased by €0.1 Mil from Dec. 2023 to Dec. 2024 .


Gossamer Bio Change In Prepaid Assets Historical Data

The historical data trend for Gossamer Bio's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gossamer Bio Change In Prepaid Assets Chart

Gossamer Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Prepaid Assets
Get a 7-Day Free Trial Premium Member Only -1.35 2.33 0.28 -3.57 0.06

Gossamer Bio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.72 -1.78 1.93 0.59 -0.86

Gossamer Bio Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gossamer Bio Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Gossamer Bio's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Gossamer Bio Business Description

Traded in Other Exchanges
Address
3115 Merryfield Row, Suite 120, San Diego, CA, USA, 92121
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio Headlines

No Headlines